1990: BS, Howard University, Physician Assistant
1998: MD, University of Maryland School of Medicine
Post Graduate Education and Training
1998-2001: Internal Medicine Internship & Residency, Walter Reed Army Medical Center (WRAMC)
2002-2005: Infectious Disease Fellowship, WRAMC
1990: Primary Care Certificate, Physician Assistant
2001: American Board of Internal Medicine Diplomate, Internal Medicine
2006: American Board of Internal Medicine Diplomate, Infectious Disease
Research Interests:2002: Sub-Investigator on IND protocol for the use of ribavarin in treating patients from the Balkans with suspected hemorrhagic fever. Landstuhl Regional Medical Center, Landstuhl, Germany.
2003-2005: Principal Investigator (ID fellow) of behavior research study involving knowledge, beliefs and attitudes of HIV+ individuals regarding smallpox.
Principal Investigator (ID Fellow) of multi-site study in collaboration with investigators at WRAIR to define the association of polymorphisms in the MDR1 gene with clinical response to efavirenz in HIV-1 infected military patients stratified by ethnic self-reporting. WRAMC, Washington, DC.
Member (ID Fellow) of the Walter Reed Clinical Leishmaniasis Group Protocol investigating "Sodium Stibogluconate Treatment of Leishmaniasis." Clinical Presentations of Cutaneous Leishmaniasis in U.S. Military Deployed to Iraq. The American Society of Tropical Medicine and Hygiene, 53RD Annual Meeting, Miami Beach, Florida, 7-11 November, 2004.
2004-2009: Associate Investigator (ID Fellow) on protocol, "Tissue Banking of Biopsy Samples for the Validation of Molecular Assays for the Diagnosis of Leishmaniasis" at WRAMC.
2005-2008: Associate Investigator, RV 158, "A Phase I Double-Blind, Randomized, Dose Escalating, Placebo-Controlled, Study of Safety and Immunogenicity of WRAIR/NIH Live Recombinant MVA-CMDR (HIV-1 CM235 env/CM240 gag/pol) Administered by Intramuscular (IM) or Intradermal (ID) Route In HIV-Uninfected Adults."
2006-2009: Associate Investigator, RV 151, "A Phase I Study of Safety and Immunogenicity of the WRAIR HIV-1 Vaccine Lfn-p24 administered by the Intramuscular (IM) Route in Healthy Adults."
Associate Investigator, "Phase 1 Trial To Evaluate The Safety and Immunogenicity of a Trivalent HIV-1, +/-IL15, MVA Boost Vaccine."
Associate Investigator, RV 179, "Collection and Processing of Blood from Healthy Donors for In Vitro Researchâ?
Associate Investigator, RV 177, "Surveillance of HIV Infection among Civilian Applicants for U.S. Military Service and U.S. Department of Defense Military Personnel."
2007-2009: Associate Investigator, RV 161, "Seroepidemiologic Case-Control Study of HIV-1 Infected and Non-Infected U.S. Military Service Members."
Associate Investigator, RV 190, "A Seroepidemiologic Investigation of HIV-1 Seroconversions among U.S. Military Servicemembers Deployed to Operation Enduring Freedom/Operation Iraqi Freedom (OEF/OIF) 2001-2005."
Principal Investigator, "Molecular Epidemiology of HIV-1 in Bulgaria."
Principal Investigator, "Molecular Epidemiology of HIV-1 in Romania."
2010-present: Member, Institutional Review Board
Clinical Speciality:Infectious Diseases; HIV
Peer-Reviewed Journal Articles